Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma

Peking University First Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
radiotherapy
upper tract urothelial carcinoma, utuc, her2, disitamab vedotin, radiotherapy, adjuvant therapy, cisplatin-ineligible, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873620
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.